IL97885A0 - Growth hormone releasing factor analogs - Google Patents

Growth hormone releasing factor analogs

Info

Publication number
IL97885A0
IL97885A0 IL97885A IL9788591A IL97885A0 IL 97885 A0 IL97885 A0 IL 97885A0 IL 97885 A IL97885 A IL 97885A IL 9788591 A IL9788591 A IL 9788591A IL 97885 A0 IL97885 A0 IL 97885A0
Authority
IL
Israel
Prior art keywords
growth hormone
releasing factor
hormone releasing
analogs
compounds
Prior art date
Application number
IL97885A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL97885A0 publication Critical patent/IL97885A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Slot Machines And Peripheral Devices (AREA)
IL97885A 1990-04-24 1991-04-17 Growth hormone releasing factor analogs IL97885A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51373090A 1990-04-24 1990-04-24
US58732390A 1990-09-24 1990-09-24

Publications (1)

Publication Number Publication Date
IL97885A0 true IL97885A0 (en) 1992-06-21

Family

ID=27057991

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97885A IL97885A0 (en) 1990-04-24 1991-04-17 Growth hormone releasing factor analogs

Country Status (18)

Country Link
EP (1) EP0454367B1 (de)
JP (1) JPH04305598A (de)
KR (1) KR910018546A (de)
CN (1) CN1066345C (de)
AT (1) ATE186570T1 (de)
AU (1) AU643773B2 (de)
CA (1) CA2040649A1 (de)
DE (1) DE69131771T2 (de)
DK (1) DK0454367T3 (de)
ES (1) ES2141085T3 (de)
FI (1) FI911961A7 (de)
GR (1) GR3032384T3 (de)
HU (1) HUT60634A (de)
IE (1) IE911358A1 (de)
IL (1) IL97885A0 (de)
NO (1) NO911609L (de)
NZ (1) NZ237857A (de)
PT (1) PT97414A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973114A (en) * 1992-06-23 1999-10-26 The University Of Virginia Patent Foundation Isolation and characterization of the growth hormone releasing hormone receptor
BR112013027150A2 (pt) * 2011-04-21 2017-06-06 Theratechnologies Inc thera
CN109180800B (zh) * 2018-08-01 2019-07-12 广东药科大学 新型生长激素释放激素类似肽二聚体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728609A (en) 1983-01-10 1988-03-01 Hoffmann-La-Roche Inc. Recombinant growth hormone releasing factor
US4617149A (en) 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
IT1234977B (it) 1985-03-22 1992-06-09 Serono Ist Farm Espressione in e. coli polipeptidi ibridi contenenti la sequenza del fattore di rilascio dell'ormone della crescita
US4734399A (en) 1985-08-06 1988-03-29 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
PT83613B (en) 1985-10-28 1988-11-21 Lilly Co Eli Process for the selective chemical removal of a protein amino-terminal residue
IL86102A (en) * 1987-05-11 1994-04-12 Univ Tulane Alkylated growth hormone-releasing peptides and use thereof
IL91771A0 (en) * 1988-09-30 1990-06-10 Lilly Co Eli Increased expression of small molecular weight recombinant proteins

Also Published As

Publication number Publication date
GR3032384T3 (en) 2000-04-27
DE69131771D1 (de) 1999-12-16
ES2141085T3 (es) 2000-03-16
PT97414A (pt) 1992-01-31
EP0454367A2 (de) 1991-10-30
AU7525091A (en) 1991-11-07
NO911609L (no) 1991-10-25
EP0454367B1 (de) 1999-11-10
FI911961L (fi) 1991-10-25
EP0454367A3 (en) 1992-07-29
NZ237857A (en) 1992-05-26
AU643773B2 (en) 1993-11-25
FI911961A0 (fi) 1991-04-23
CA2040649A1 (en) 1991-10-25
DE69131771T2 (de) 2000-04-06
ATE186570T1 (de) 1999-11-15
FI911961A7 (fi) 1991-10-25
JPH04305598A (ja) 1992-10-28
HU911358D0 (en) 1991-10-28
KR910018546A (ko) 1991-11-30
CN1057784A (zh) 1992-01-15
IE911358A1 (en) 1991-11-06
DK0454367T3 (da) 2000-03-27
NO911609D0 (no) 1991-04-23
CN1066345C (zh) 2001-05-30
HUT60634A (en) 1992-10-28

Similar Documents

Publication Publication Date Title
EP0355460A3 (de) Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung
ATE140969T1 (de) Il-3 mit zusätzlichen cysteinresten und chemische modifikationen davon
GR3030703T3 (en) Process for the production of biologically active protein (e.g. TGF)
HUT56583A (en) Process for producing peptide derivatives and pharmaceutical and diagnostic compositions comprising such compounds
AU575843B2 (en) Growth hormone releasing peptides
HUT55801A (en) Process for producing anti-coagulative peptides marked with radioactivity
IL106271A0 (en) Tnf inhibitors
PT87523A (pt) Mischkristalle aus insulin und insulinderivaten verfahren zur herstellung dieser mischkristalle diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
HU904201D0 (en) Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds
HU9300192D0 (en) Polypeptide compounds promoting growth hormone emission
AU643773B2 (en) Growth hormone releasing factor analogs
DE3270446D1 (en) Diamides of substituted hydroxymalonic acids, process for their preparation and their use as pesticides
DK13888D0 (da) Krystallinsk cefadroxil, fremgangsmaade til dets fremstilling, og farmaceutisk praeparat indeholdende et saadant
HUT47375A (en) Fungicide compositions containing /2-cyano-2-oximino-acetyl/-aminoacid derivatives as active components and process for producing the active components
EG18296A (en) Novel phenylureas
PT87628A (pt) Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives
CA2087450A1 (en) Stable and bioactive modified somatotropins
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
DE69017146D1 (de) Verfahren zur Herstellung von 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbonsäurethioamid-1-(1R,2R)oxyden, die so erhaltenen 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbothioamid-1-(1R,2R)oxyde und diese enthaltende pharmazeutische Zusammenstellungen.
YU73891A (sh) Analozi faktora koji oslobadjaju hormon rasta
MD57C2 (ro) Procedeu de obţinere a eterilor compuşi ai acidului 5-clor-3-clorsulfonil-2-tiofencarbonic